LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 8 of total 8

Search options

  1. Article ; Online: Innovative Guide Extension Catheter Trapping Technique to Retrieve a Lost Stent From a Coronary Artery.

    Righetti, Stefano / Tresoldi, Simone / Calchera, Ivan / Alvarenga, Carlos Enrique / Vandoni, Pietro

    JACC. Case reports

    2022  Volume 4, Issue 7, Page(s) 411–414

    Abstract: A stent that was being implanted in the left circumflex artery, to treat an iatrogenic dissection, became dislodged at the ostial left circumflex artery on a previously deployed stent implanted for the treatment of a distal left main bifurcation stenosis. ...

    Abstract A stent that was being implanted in the left circumflex artery, to treat an iatrogenic dissection, became dislodged at the ostial left circumflex artery on a previously deployed stent implanted for the treatment of a distal left main bifurcation stenosis. We describe here a novel technique to retrieve the device safely. (
    Language English
    Publishing date 2022-04-06
    Publishing country Netherlands
    Document type Case Reports
    ISSN 2666-0849
    ISSN (online) 2666-0849
    DOI 10.1016/j.jaccas.2022.02.005
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

    Inter-library loan at ZB MED

    Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

  2. Article ; Online: Outcomes Related to Antiplatelet Therapy in a High-Risk ST-Segment Elevation Myocardial Infarction Population: A Retrospective Real-World Analysis of an Italian ECMO Center.

    Righetti, Stefano / Montemerlo, Elisabetta / Soffici, Federica / Sala, Davide / Bozzano, Alessandro / Mauro, Andrea / Maggioni, Elena / Avalli, Leonello / Camisasca, Paola / Colombo, Virgilio / Achilli, Felice / Lettino, Maddalena / Calchera, Ivan

    Journal of cardiovascular pharmacology and therapeutics

    2019  Volume 25, Issue 3, Page(s) 219–225

    Abstract: Aim: To evaluate outcomes related to antiplatelet therapy in patients with ST-elevation myocardial infarction (STEMI) admitted to the San Gerardo Hospital in Monza, an extracorporeal membrane oxygenation (ECMO) reference center in the Monza-Brianza area. ...

    Abstract Aim: To evaluate outcomes related to antiplatelet therapy in patients with ST-elevation myocardial infarction (STEMI) admitted to the San Gerardo Hospital in Monza, an extracorporeal membrane oxygenation (ECMO) reference center in the Monza-Brianza area.
    Methods: This retrospective study enrolled patients with STEMI hospitalized between 2013 and 2017.
    Results: This study included 653 patients (mean age: 67.5 years, 71% male). Across the study period, ticagrelor use showed consistent increases, from 22% of patients during 2013 to 85% in 2017. Cardiac arrest prehospitalization occurred in 100 patients (15.3%), either at home (n = 85, 13.0%) or during transfer (n = 15, 2.3%); 46 patients underwent ECMO for refractory cardiac arrest. Rates of 90-day survival (hazard ratio [HR]: 2.4, 95% confidence interval [CI]: 1.3-4.4,
    Conclusions: Changes in the treatment of high-risk patients with STEMI over time are in line with changes in treatment guidelines. In these patients, ticagrelor is associated with significantly improved 90-day mortality compared with clopidogrel.
    MeSH term(s) Aged ; Aged, 80 and over ; Clopidogrel/adverse effects ; Clopidogrel/therapeutic use ; Extracorporeal Membrane Oxygenation/adverse effects ; Extracorporeal Membrane Oxygenation/mortality ; Female ; Humans ; Italy ; Male ; Middle Aged ; Platelet Aggregation Inhibitors/adverse effects ; Platelet Aggregation Inhibitors/therapeutic use ; Retrospective Studies ; Risk Assessment ; Risk Factors ; ST Elevation Myocardial Infarction/diagnosis ; ST Elevation Myocardial Infarction/mortality ; ST Elevation Myocardial Infarction/physiopathology ; ST Elevation Myocardial Infarction/therapy ; Ticagrelor/adverse effects ; Ticagrelor/therapeutic use ; Time Factors ; Treatment Outcome
    Chemical Substances Platelet Aggregation Inhibitors ; Clopidogrel (A74586SNO7) ; Ticagrelor (GLH0314RVC)
    Language English
    Publishing date 2019-12-23
    Publishing country United States
    Document type Comparative Study ; Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1329372-2
    ISSN 1940-4034 ; 1074-2484
    ISSN (online) 1940-4034
    ISSN 1074-2484
    DOI 10.1177/1074248419896129
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    In stock of ZB MED Cologne/Königswinter

    Zs.A 4895: Show issues Location:
    Je nach Verfügbarkeit (siehe Angabe bei Bestand)
    bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
    Jg. 1995 - 2021: Lesesall (2.OG)
    ab Jg. 2022: Lesesaal (EG)

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  3. Article ; Online: Dual antiplatelet therapy prolongation in high-risk patients with prior myocardial infarction: insights from the post-PCI registry.

    Ferlini, Marco / Rossini, Roberta / Musumeci, Giuseppe / Cornara, Stefano / Somaschini, Alberto / Grieco, Niccolò / Marino, Marcello / Calchera, Ivan / Cardile, Antonino / Colombo, Paola / Martinoni, Alessandro / Ielasi, Alfonso / Castiglioni, Battistina / Lettieri, Corrado / Tarantini, Giuseppe / Oltrona Visconti, Luigi

    Journal of cardiovascular medicine (Hagerstown, Md.)

    2020  Volume 21, Issue 8, Page(s) 603–609

    Abstract: Background: Patients surviving a myocardial infarction (MI) are at a heightened risk for recurrent ischemic events that can be reduced with the long-term addition of a second antithrombotic drug to aspirin. However, data about real prescription of this ... ...

    Abstract Background: Patients surviving a myocardial infarction (MI) are at a heightened risk for recurrent ischemic events that can be reduced with the long-term addition of a second antithrombotic drug to aspirin. However, data about real prescription of this therapy are lacking and sometimes controversial.
    Methods: We aimed to describe the incidence and the determinants of a dual antiplatelet therapy (DAPT) prolongation beyond 12 months in a cohort of consecutive patients undergoing percutaneous coronary intervention (PCI) with prior MI undergoing PCI and features of high ischemic risk intended as age more than 65 years, second MI, type 2 diabetes mellitus, multivessel coronary artery disease (MVCAD) and chronic kidney disease (CKD). We analysed patients enrolled in the prospective 'Post-PCI' registry that included patients treated with PCI for stable coronary artery disease (CAD) or acute coronary syndromes. At 12 months' follow-up, we collected data about DAPT prolongation in patients with prior MI and at least one of the previous features of high risk who did not experience ischemic and bleeding events during the follow-up.
    Results: Among 1113 patients included in the registry, 778 (72%) presented the inclusion criteria for the present study: 434 (66%) were more than 65 years old, 245 (37%) had a second MI, 189 (29%) diabetes mellitus, 480 (73%) MVCAD and 216 (33%) CKD. Despite a DAPT being prescribed for 1 year in 86% of the patients, it was prolonged for over 12 months in 105 (16%) of them. At multivariable analysis, only second MI and MVCAD were independent predictors of DAPT prolongation in a model including age more than 65 years, diabetes mellitus, CKD and PCI on left main/left anterior descending coronary artery. We found no significant difference in DAPT prolongation according to a DAPT-score value at least 2 or based on the physician who actually performed the follow-up (clinical cardiologist, interventional cardiologist or other).
    Conclusion: In patients with prior MI and features of high ischemic risk undergoing PCI, the rate of DAPT prolongation beyond 12 months was low; recurrent MI and MVCAD appeared as its main determinants.
    MeSH term(s) Aged ; Drug Administration Schedule ; Dual Anti-Platelet Therapy/adverse effects ; Dual Anti-Platelet Therapy/mortality ; Female ; Hemorrhage/chemically induced ; Humans ; Italy ; Male ; Middle Aged ; Myocardial Infarction/diagnostic imaging ; Myocardial Infarction/mortality ; Myocardial Infarction/therapy ; Percutaneous Coronary Intervention/adverse effects ; Percutaneous Coronary Intervention/mortality ; Recurrence ; Registries ; Retrospective Studies ; Risk Assessment ; Risk Factors ; Time Factors ; Treatment Outcome
    Language English
    Publishing date 2020-06-10
    Publishing country United States
    Document type Journal Article ; Multicenter Study ; Observational Study
    ZDB-ID 2223461-5
    ISSN 1558-2035 ; 1558-2027
    ISSN (online) 1558-2035
    ISSN 1558-2027
    DOI 10.2459/JCM.0000000000000988
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    In stock of ZB MED Cologne/Königswinter

    Zs.A 5210: Show issues Location:
    Je nach Verfügbarkeit (siehe Angabe bei Bestand)
    bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
    Jg. 1995 - 2021: Lesesall (2.OG)
    ab Jg. 2022: Lesesaal (EG)
    Zs.MO 559: Show issues

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  4. Article ; Online: Effects of extracorporeal cardiopulmonary resuscitation on neurological and cardiac outcome after ischaemic refractory cardiac arrest.

    Cesana, Francesca / Avalli, Leonello / Garatti, Laura / Coppo, Anna / Righetti, Stefano / Calchera, Ivan / Scanziani, Elisabetta / Cozzolino, Paolo / Malafronte, Cristina / Mauro, Andrea / Soffici, Federica / Sulmina, Endrit / Bozzon, Veronica / Maggioni, Elena / Foti, Giuseppe / Achilli, Felice

    European heart journal. Acute cardiovascular care

    2017  Volume 7, Issue 5, Page(s) 432–441

    Abstract: Background: Extracorporeal cardiopulmonary resuscitation is increasingly recognised as a rescue therapy for refractory cardiac arrest, nevertheless data are scanty about its effects on neurologic and cardiac outcome. The aim of this study is to compare ... ...

    Abstract Background: Extracorporeal cardiopulmonary resuscitation is increasingly recognised as a rescue therapy for refractory cardiac arrest, nevertheless data are scanty about its effects on neurologic and cardiac outcome. The aim of this study is to compare clinical outcome in patients with cardiac arrest of ischaemic origin (i.e. critical coronary plaque during angiography) and return of spontaneous circulation during conventional cardiopulmonary resuscitation vs refractory cardiac arrest patients needing extracorporeal cardiopulmonary resuscitation. Moreover, we tried to identify predictors of survival after successful cardiopulmonary resuscitation.
    Methods: We enrolled 148 patients with ischaemic cardiac arrest admitted to our hospital from 2011-2015. We compared clinical characteristics, cardiac arrest features, neurological and echocardiographic data obtained after return of spontaneous circulation (within 24 h, 15 days and six months).
    Results: Patients in the extracorporeal cardiopulmonary resuscitation group ( n=63, 43%) were younger (59±9 vs 63±8 year-old, p=0.02) with lower incidence of atherosclerosis risk factors than those with conventional cardiopulmonary resuscitation. In the extracorporeal cardiopulmonary resuscitation group, left ventricular ejection fraction was lower than conventional cardiopulmonary resuscitation at early echocardiography (19±16% vs 37±11 p<0.01). Survivors in both groups showed similar left ventricular ejection fraction 15 days and 4-6 months after cardiac arrest (46±8% vs 49±10, 47±11% vs 45±13%, p not significant for both), despite a major extent and duration of cardiac ischaemia in extracorporeal cardiopulmonary resuscitation patients. At multivariate analysis, the total cardiac arrest time was the only independent predictor of survival.
    Conclusions: Extracorporeal cardiopulmonary resuscitation patients are younger and have less comorbidities than conventional cardiopulmonary resuscitation, but they have worse survival and lower early left ventricular ejection fraction. Survivors after extracorporeal cardiopulmonary resuscitation have a neurological outcome and recovery of heart function comparable to subjects with return of spontaneous circulation. Total cardiac arrest time is the only predictor of survival after cardiopulmonary resuscitation in both groups.
    MeSH term(s) Adolescent ; Adult ; Aged ; Cardiopulmonary Resuscitation/methods ; Coronary Angiography ; Coronary Occlusion/complications ; Coronary Occlusion/diagnosis ; Extracorporeal Membrane Oxygenation/methods ; Female ; Heart Arrest/etiology ; Heart Arrest/mortality ; Heart Arrest/therapy ; Humans ; Italy/epidemiology ; Male ; Middle Aged ; Retrospective Studies ; Risk Factors ; Survival Rate/trends ; Treatment Outcome ; Young Adult
    Language English
    Publishing date 2017-10-24
    Publishing country England
    Document type Comparative Study ; Journal Article
    ZDB-ID 2663340-1
    ISSN 2048-8734 ; 2048-8726
    ISSN (online) 2048-8734
    ISSN 2048-8726
    DOI 10.1177/2048872617737041
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  5. Article ; Online: G-CSF treatment for STEMI: final 3-year follow-up of the randomised placebo-controlled STEM-AMI trial.

    Achilli, Felice / Malafronte, Cristina / Maggiolini, Stefano / Lenatti, Laura / Squadroni, Lidia / Gibelli, Giuseppe / Capogrossi, Maurizio C / Dadone, Viola / Gentile, Francesco / Bassetti, Beatrice / Di Gennaro, Filiberto / Camisasca, Paola / Calchera, Ivan / Valagussa, Laura / Colombo, Gualtiero I / Pompilio, Giulio

    Heart (British Cardiac Society)

    2014  Volume 100, Issue 7, Page(s) 574–581

    Abstract: Objective: To assess whether granulocyte colony-stimulating factor (G-CSF) treatment induces a sustained benefit on adverse remodelling in patients with large anterior ST-elevation myocardial infarction (STEMI) and left ventricular (LV) dysfunction ... ...

    Abstract Objective: To assess whether granulocyte colony-stimulating factor (G-CSF) treatment induces a sustained benefit on adverse remodelling in patients with large anterior ST-elevation myocardial infarction (STEMI) and left ventricular (LV) dysfunction after successful reperfusion.
    Methods: The STEM-AMI Trial was a prospective, placebo-controlled, multicentre study. Sixty consecutive patients with a first anterior STEMI, who underwent primary percutaneous coronary intervention 2-12 h after symptom onset, with LV ejection fraction (LVEF) ≤45% measured by echocardiography within 12 h after successful revascularisation (TIMI flow score ≥2), were randomised 1:1 to G-CSF (5 µg/Kg body weight b.i.d.) or placebo. Clinical events and Major Adverse Cardiac and Cerebrovascular Event (MACCE) were monitored, and LVEF, LV end-diastolic (LVEDV) and end-systolic (LVESV) volumes, and infarct size were evaluated by MRI at the final 3-year follow-up.
    Results: Fifty-four patients completed the study, of whom 35 with MRI. No significant differences were found in mortality and MACCE between G-CSF and placebo-treated groups. The 3-year infarct size was not different between groups, whereas LVEDV was significantly lower in G-CSF (n=20) than in placebo (n=15) patients (170.1±8.1 vs 197.2±8.9 mL, respectively; p=0.033 at analysis of covariance). A significant inverse correlation was detected in G-CSF patients between the number of circulating CD34 cells at 30 days after reperfusion and the 3-year absolute and indexed LVEDV (ρ=-0.71, 95% CI -0.90 to -0.30, and ρ=-0.62, -0.86 to -0.14, respectively), or their change over time (r=-0.59, -0.85 to -0.11, and r=-0.55, -0.83 to -0.06, respectively).
    Conclusions: G-CSF therapy may be beneficial in attenuating ventricular remodelling subsequent to a large anterior STEMI in the long term. No differences have been detected in clinical outcome.
    MeSH term(s) Female ; Follow-Up Studies ; Granulocyte Colony-Stimulating Factor/therapeutic use ; Humans ; Male ; Middle Aged ; Myocardial Infarction/complications ; Myocardial Infarction/physiopathology ; Myocardial Infarction/therapy ; Prospective Studies ; Time Factors ; Ventricular Dysfunction, Left/etiology ; Ventricular Dysfunction, Left/prevention & control ; Ventricular Remodeling
    Chemical Substances Granulocyte Colony-Stimulating Factor (143011-72-7)
    Language English
    Publishing date 2014-04
    Publishing country England
    Document type Journal Article ; Multicenter Study ; Randomized Controlled Trial ; Research Support, Non-U.S. Gov't
    ZDB-ID 1303417-0
    ISSN 1468-201X ; 1355-6037
    ISSN (online) 1468-201X
    ISSN 1355-6037
    DOI 10.1136/heartjnl-2013-304955
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    In stock of ZB MED Cologne/Königswinter

    Ui IV Zs.40: Show issues Location:
    Je nach Verfügbarkeit (siehe Angabe bei Bestand)
    bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
    ab Jg. 2022: Lesesaal (EG)
    Zs.MO 112: Show issues

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  6. Article ; Online: Persistence of arterial functional abnormalities after successful coronary revascularization.

    Giannattasio, Cristina / Capra, Anna C M / Calchera, Ivan / Colombo, Virgilio / Cesana, Francesca / Nava, Stefano / Maloberti, Alessandro / Alloni, Marta / Facchetti, Rita / Trocino, Giuseppe / Grassi, Guido / Paolini, Giovanni / Mancia, Giuseppe

    Journal of hypertension

    2011  Volume 29, Issue 7, Page(s) 1374–1379

    Abstract: Background: In patients with myocardial ischemia and coronary atherosclerosis, arterial stiffness and endothelial function are impaired. Whether these alterations can be favorably affected by successful coronary revascularization is debated.: Methods!# ...

    Abstract Background: In patients with myocardial ischemia and coronary atherosclerosis, arterial stiffness and endothelial function are impaired. Whether these alterations can be favorably affected by successful coronary revascularization is debated.
    Methods: We studied 39 hospitalized patients 59.3 ± 3.2 years old (mean ± SEM). In 21 patients with angiographic evidence of significant coronary artery stenosis, revascularization procedures were performed (stenting n = 11 and bypass surgery n = 10). The remaining patients had no significant stenosis and thus served as controls. Prerevascularization measurements included carotido-femoral pulse wave velocity (PWV), radial artery flow-mediated vasodilatation and a complete echocardiographic examination. The same measurements were performed 6 months later. Pharmacological treatment consisted of different cardiovascular drugs and remained substantially unchanged over the 6-month follow-up period.
    Results: With the exception of an increased left ventricular mass index (LVMI; 130 ± 5.3 versus 105.8 ± 7.2 g/m(2), P < 0.05) and a lower Em/Am (0.6 ± 0.01 and 0.8 ± 0.01 respectively, P < 0.05) observed in patients with coronary stenosis, all other hemodynamic, cardiac and vascular variables were similar in the two groups. Following the 6-month follow-up period, all variables remained substantially unchanged, with the exception, in revascularized patients, of a significant reduction in LVMI (-12%, P < 0.05) and an improvement in Tissue Doppler Imaging-measured diastolic function (Em/Am + 30%, P < 0.05). This was not associated, however, with any significant change in PWV and in flow-mediated vasodilatation.
    Conclusion: Cardiac revascularization has no effect on arterial function, assessed either as arterial stiffness or as flow-mediated vasodilatation. On the contrary, the improvement in coronary blood flow triggers local cardiac changes, namely, a reduction in LVMI and an improvement in diastolic function.
    MeSH term(s) Case-Control Studies ; Coronary Stenosis/physiopathology ; Coronary Vessels/physiopathology ; Female ; Humans ; Male ; Middle Aged
    Language English
    Publishing date 2011-07
    Publishing country England
    Document type Journal Article
    ZDB-ID 605532-1
    ISSN 1473-5598 ; 0263-6352 ; 0952-1178
    ISSN (online) 1473-5598
    ISSN 0263-6352 ; 0952-1178
    DOI 10.1097/HJH.0b013e328347a0e3
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    In stock of ZB MED Cologne/Königswinter

    Zs.A 1885: Show issues Location:
    Je nach Verfügbarkeit (siehe Angabe bei Bestand)
    bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
    Jg. 1995 - 2021: Lesesall (1.OG)
    ab Jg. 2022: Lesesaal (EG)
    Zs.MO 614: Show issues

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  7. Article: Cardiac, neuroadrenergic, and portal hemodynamic effects of prolonged aldosterone blockade in postviral child A cirrhosis.

    Pozzi, Massimo / Grassi, Guido / Ratti, Laura / Favini, Giorgio / Dell'Oro, Raffaella / Redaelli, Elena / Calchera, Ivan / Boari, Giuseppe / Mancia, Giuseppe

    The American journal of gastroenterology

    2005  Volume 100, Issue 5, Page(s) 1110–1116

    Abstract: Objectives: The present study was designed to determine the effects of long-term antialdosterone treatment on cardiac structural and functional alterations, portal and systemic hemodynamic as well as adrenergic dysfunction characterizing Child A ... ...

    Abstract Objectives: The present study was designed to determine the effects of long-term antialdosterone treatment on cardiac structural and functional alterations, portal and systemic hemodynamic as well as adrenergic dysfunction characterizing Child A cirrhotic patients with F1 esophageal varices.
    Methods: Twenty-two Child A postviral preascitic cirrhotic patients were randomly allocated to 200 mg/day K-Canrenoate (13 patients, age 59.6 +/- 2.2 yr, mean + SEM) or no-drug treatment (9 patients, age 61.8 +/- 2.3) for a 6-month-period. Measurements, which included hepatic venous pressure gradient (HVPG), left ventricular wall thickness, left ventricular end-diastolic volume and diastolic function (LVWT, LVEDV, and E/A ratio, echocardiography), and muscle sympathetic nerve activity (MSNA, microneurography, peroneal nerve), were obtained at baseline and following 6 months of drug or no-drug treatment. Ten healthy age-matched subjects served as controls.
    Results: Cirrhotic patients were characterized by increased HVPG, LVWT, and MSNA values and by a depressed E/A ratio. K-Canrenoate treatment significantly reduced HVPG (from 15.3 +/- 1.0 to 13.8 +/- 0.8 mmHg, p < 0.05), LVWT (from 21.8 +/- 0.5 to 20.7 +/- 0.6 mm, p < 0.02), and LVEDV (from 99.2 +/- 7 to 86.4 +/- 6 ml, p < 0.01), leaving E/A ratio and MSNA almost unaltered. No significant change was observed in the untreated group of cirrhotic patients followed for 6 months without intervention.
    Conclusions: These data provide evidence that aldosterone blockade by long-term K-Canrenoate administration improves hepatic hemodynamics by lowering HVPG and ameliorates cardiac structure and function by favoring a reduction in LVWT and LVEDV as well. They also show, however, that this therapeutic intervention neither improves left ventricular diastolic dysfunction nor exerts sympathoinhibitory effects.
    MeSH term(s) Adrenergic Fibers/drug effects ; Canrenoic Acid/therapeutic use ; Case-Control Studies ; Diastole/drug effects ; Esophageal and Gastric Varices/drug therapy ; Female ; Heart/drug effects ; Heart Ventricles/drug effects ; Hemodynamics/drug effects ; Hepatic Veins/drug effects ; Hepatitis B/complications ; Hepatitis C/complications ; Humans ; Liver Circulation/drug effects ; Liver Cirrhosis/drug therapy ; Liver Cirrhosis/physiopathology ; Liver Cirrhosis/virology ; Longitudinal Studies ; Male ; Middle Aged ; Mineralocorticoid Receptor Antagonists/therapeutic use ; Peroneal Nerve/drug effects ; Portal System/drug effects ; Stroke Volume/drug effects ; Venous Pressure/drug effects
    Chemical Substances Mineralocorticoid Receptor Antagonists ; Canrenoic Acid (87UG89VA9K)
    Language English
    Publishing date 2005-05
    Publishing country United States
    Document type Clinical Trial ; Comparative Study ; Journal Article ; Randomized Controlled Trial
    ZDB-ID 390122-1
    ISSN 1572-0241 ; 0002-9270
    ISSN (online) 1572-0241
    ISSN 0002-9270
    DOI 10.1111/j.1572-0241.2005.41060.x
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    In stock of ZB MED Cologne/Königswinter

    Ui V Zs.36: Show issues Location:
    Je nach Verfügbarkeit (siehe Angabe bei Bestand)
    bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
    ab Jg. 2022: Lesesaal (EG)

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  8. Article: Update del documento di posizione della Società Italiana di Cardiologia Interventistica (SICI-GISE) sui requisiti minimi per ospedali ed operatori che eseguono procedure di impianto transcatetere di protesi valvolare aortica.

    Tarantini, Giuseppe / Esposito, Giovanni / Musumeci, Giuseppe / Fraccaro, Chiara / Franzone, Anna / Castiglioni, Battistina / La Manna, Alessio / Limbruno, Ugo / Marchese, Alfredo / Mauro, Ciro / Rigattieri, Stefano / Tarantino, Fabio / Gandolfo, Caterina / Santoro, Gennaro / Violini, Roberto / Airoldi, Flavio / Albiero, Remo / Balbi, Manrico / Baralis, Giorgio /
    Bartorelli, Antonio Luca / Bedogni, Francesco / Benassi, Alberto / Berni, Andrea / Bonzani, Giulio / Bortone, Alessandro Santo / Braito, Giuseppe / Briguori, Carlo / Brscic, Elvis / Calabrò, Paolo / Calchera, Ivan / Cappelli Bigazzi, Maurizio / Caprioglio, Francesco / Castriota, Fausto / Cernetti, Carlo / Cicala, Cinzia / Cioffi, Paolo / Colombo, Antonio / Colombo, Virgilio / Contegiacomo, Gaetano / Cremonesi, Alberto / D'Amico, Maurizio / De Benedictis, Mauro / De Leo, Alessandro / Di Biasi, Maurizio / Di Girolamo, Domenico / Di Lorenzo, Emilio / Di Mario, Carlo / Dominici, Marcello / Ettori, Federica / Ferrario, Maurizio / Fioranelli, Massimo / Fischetti, Dionigi / Gabrielli, Gabriele / Giordano, Arturo / Giudice, Pietro / Greco, Cesare / Indolfi, Ciro / Leonzi, Ornella / Lettieri, Corrado / Loi, Bruno / Maddestra, Nicola / Marchionni, Niccolò / Marrozzini, Cinzia / Medda, Massimo / Missiroli, Bindo / My, Luigi / Oreglia, Jacopo Andrea / Palmieri, Cataldo / Pantaleo, Paolo / Paparoni, Saro Roberto / Parodi, Guido / Petronio, Anna Sonia / Piatti, Luigi / Piccaluga, Emanuela / Pierli, Carlo / Perkan, Andrea / Pitì, Antonino / Poli, Arnaldo / Ramondo, Angelo Bruno / Reale, Maurizio Alessandro / Reimers, Bernhard / Ribichini, Flavio Luciano / Rosso, Roberta / Saccà, Salvatore / Sacra, Cosimo / Santarelli, Andrea / Sardella, Gennaro / Satullo, Gaetano / Scalise, Filippo / Siviglia, Massimo / Spedicato, Leonardo / Stabile, Amerigo / Tamburino, Corrado / Tesorio, Tullio Nicola Maria / Tolaro, Salvatore / Tomai, Fabrizio / Trani, Carlo / Valenti, Renato / Valsecchi, Orazio / Valva, Giuseppe / Varbella, Ferdinando / Vigna, Carlo / Vignali, Luigi / Berti, Sergio

    Giornale italiano di cardiologia (2006)

    2018  Volume 19, Issue 9, Page(s) 519–529

    Abstract: Transcatheter aortic valve implantation (TAVI) has revolutionized the management of patients with symptomatic severe aortic stenosis and has become the standard of care for inoperable patients and the preferred therapy for those at increased surgical ... ...

    Title translation Updated SICI-GISE position paper on institutional and operator requirements for transcatheter aortic valve implantation.
    Abstract Transcatheter aortic valve implantation (TAVI) has revolutionized the management of patients with symptomatic severe aortic stenosis and has become the standard of care for inoperable patients and the preferred therapy for those at increased surgical risk with peculiar clinical and anatomic features. Technology advances, growing experience and accumulating data prompted the update of the 2011 Italian Society of Interventional Cardiology (SICI-GISE) position paper on institutional and operator requirements to perform TAVI. The main objective of this document is to provide a guidance to assess the potential of institutions and operators to initiate and maintain an efficient TAVI program.
    MeSH term(s) Aortic Valve Stenosis/physiopathology ; Aortic Valve Stenosis/surgery ; Biomedical Technology/trends ; Humans ; Italy ; Program Development/methods ; Severity of Illness Index ; Transcatheter Aortic Valve Replacement/instrumentation ; Transcatheter Aortic Valve Replacement/methods
    Language Italian
    Publishing date 2018-08-23
    Publishing country Italy
    Document type Journal Article ; Practice Guideline
    ZDB-ID 2272414-X
    ISSN 1972-6481 ; 1827-6806
    ISSN (online) 1972-6481
    ISSN 1827-6806
    DOI 10.1714/2951.29672
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    In stock of ZB MED Cologne/Königswinter

    Zs.A 6738: Show issues Location:
    Je nach Verfügbarkeit (siehe Angabe bei Bestand)
    bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
    ab Jg. 2022: Lesesaal (EG)

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

To top